Managing hypertension means sticking to prescribed medicines, monitoring blood pressure at home, keeping medical appointments, and making long-term lifestyle changes.
New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.